This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • To Compare the Pharmacokinetics of Tiotropium in S...
Clinical trial

To Compare the Pharmacokinetics of Tiotropium in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

Read time: 1 mins
Last updated:4th Feb 2013
The primary objective of this study is to assess and compare the pharmacokinetics (PK) of Tiotropium delivered via Breath Actuated Inhaler (BAI) (4.5 mcg/day or 9.0 mcg/day), SPIRIVA�, HandiHaler�, (18 mcg/day) and Respimat� Soft Mist� Inhaler (SMI) (5.0 mcg/day) following repeat dosing for 7 days in subjects with COPD.
Category Value
Study start date 2013-02-04

View full details